ZIMMER BIOMET HOLDINGS, INC. Goodwill and Intangible Asset Impairment
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Goodwill and Intangible Asset Impairment of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2025-02-25
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for the quarter ending 2022-12-31 was $289.80M.
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for the quarter ending 2022-09-30 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for the quarter ending 2022-06-30 was $3.00M, a 81.60% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for the quarter ending 2021-12-31 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for fiscal 2024 was $0.00.
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for fiscal 2022 was $292.80M.
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for fiscal 2020 was $503.00M.
- ZIMMER BIOMET HOLDINGS, INC. goodwill and intangible asset impairment for fiscal 2018 was $979.70M, a 195.54% increase from fiscal 2017.
| Period end | Goodwill and Intangible Asset Impairment 3 month | Goodwill and Intangible Asset Impairment 6 month | Goodwill and Intangible Asset Impairment 9 month | Goodwill and Intangible Asset Impairment 12 month | Goodwill and Intangible Asset Impairment 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 | ||||
| 2022-12-31 | $289.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $289.80M derived: sum of 2 quarters · filed 2025-02-25 | $292.80M derived: sum of 3 quarters · filed 2025-02-25 | $292.80M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.00M derived: sum of 2 quarters · filed 2023-11-07 | $3.00M 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | $3.00M 10-Q · filed 2023-08-01 | $3.00M 10-Q · filed 2023-08-01 | |||
| 2021-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2024-08-07 | $0.00 derived: sum of 2 quarters · filed 2024-08-07 | $16.30M derived: sum of 3 quarters · filed 2024-08-07 | $16.30M 8-K · filed 2024-08-07 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $16.30M derived: sum of 2 quarters · filed 2022-11-02 | $16.30M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $16.30M 10-Q · filed 2022-08-02 | $16.30M 10-Q · filed 2022-08-02 | |||
| 2020-12-31 | -$142.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$142.00M derived: sum of 2 quarters · filed 2023-02-24 | -$109.00M derived: sum of 3 quarters · filed 2023-02-24 | $503.00M 10-K · filed 2023-02-24 | $645.00M 10-K · filed 2021-02-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $33.00M derived: sum of 2 quarters · filed 2021-11-04 | $645.00M 10-Q · filed 2021-11-04 | $645.00M derived: sum of 4 quarters · filed 2022-06-22 | |
| 2020-06-30 | $33.00M 10-Q · filed 2021-08-03 | $645.00M 10-Q · filed 2021-08-03 | $645.00M derived: sum of 3 quarters · filed 2022-06-22 | $645.00M derived: sum of 4 quarters · filed 2022-06-22 | |
| 2020-03-31 | $612.00M 10-Q · filed 2021-05-04 | $612.00M derived: sum of 2 quarters · filed 2022-06-22 | $612.00M derived: sum of 3 quarters · filed 2022-06-22 | $682.10M derived: sum of 4 quarters · filed 2022-06-22 | |
| 2019-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22 | $0.00 derived: sum of 2 quarters · filed 2022-06-22 | $70.10M derived: sum of 3 quarters · filed 2022-06-22 | $70.10M 8-K · filed 2022-06-22 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $70.10M derived: sum of 2 quarters · filed 2020-11-06 | $70.10M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $70.10M 10-Q · filed 2020-08-05 | $70.10M 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | $975.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $979.70M derived: sum of 2 quarters · filed 2021-02-22 | $979.70M 10-K · filed 2021-02-22 | ||
| 2018-09-30 | $3.80M 10-Q · filed 2018-11-01 | $3.80M 10-Q · filed 2018-11-01 | |||
| 2017-12-31 | $272.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $304.70M derived: sum of 2 quarters · filed 2020-02-21 | $331.50M 10-K · filed 2020-02-21 | ||
| 2017-09-30 | $32.70M 10-Q · filed 2018-11-01 | $59.50M 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $31.10M 10-K · filed 2019-02-26 | $30.00M 10-K · filed 2018-02-27 | ||
| 2016-09-30 | $28.00M 10-Q · filed 2017-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |